Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

miR-574 decoy as novel mechanism in the control of prostaglandin formation

Diese Stellenanzeige ist abgelaufen. Finden Sie hier zahlreiche ähnliche Jobs.

Else Kröner-Fresenius PhD studentship
“miR-574 decoy as novel mechanism in the control of prostaglandin formation”
in the laboratory of Prof. Dr. Dieter Steinhilber (Goethe-University Frankfurt, Institute for Pharmaceutical Chemistry, http://www.uni-frankfurt.de/53483647/Steinhilber )
 
microRNAs play an import role in the regulation of gene expression. Within this project, we will study the function of miR-574 in the control of prostaglandin formation with special emphasis on the role of this regulatory mechanism in rheumatoid arthritis.
 
The Else Kröner-Fresenius Research Training Group “Eicosanoid and sphingolipid pathways in inflammation, cancer and vascular diseases” is an international research training group at the Goethe University Frankfurt and the Karolinska Institute in Stockholm and is funded by the Else Kröner-Fresenius-Stiftung.  The focus of this research training group is on intensifying the understanding of the physiological and pathophysiological roles of eicosanoids and sphingolipids in inflammatory processes, cancer and vascular diseases.  FIRST provides postgraduate education in all aspects of translationals biomedicine with a focus on the processes involved in drug research and development.
 
Candidates should already possess a first class MSc (biology, pharmacy or related discipline) or an MD degree.  Applications consisting of a cover letter indicating the motivation for this project as well as a full curriculum vitae containing a brief summary of previous research projects, together with copies of all relevant university certificates should be sent by email to Dr. Brigitte Held (held@pharmchem.uni-frankfurt.de).  Hard copy version can be to the postal address:  Dr. Brigitte Held, Institut für Pharmazeutische Chemie, Goethe Universität Frankfurt, Max-von-Laue-Str. 9, D - 60438 Frankfurt.  Incomplete applications will not be considered.
The application deadline is May 22nd, 2016.  Short listed applications will be required to attend a selection workshop in Frankfurt.
Stipends will be paid according to the rules of the Deutsche Forschungsgemeinschaft.
 
For further information on the projects as well as FIRST, please visit:  www.first-gradschool.de
 

Kontaktdaten


Art des Bewerbungszugangs
Applications by email preferred.
Kontakt für Bewerbungen
Dr. Brigitte Held
Institut für Pharmazeutische Chemie
Goethe Universität Frankfurt
Max-von-Laue-Str. 9
D- 60438 Frankfurt
Email:  held@pharmchem.uni-frankfurt.de

Details der Stellenanzeige


Arbeitszeit
Vollzeit
Vertragslaufzeit
Befristete Anstellung
Stellentyp
Promotionsstelle
Berufserfahrung
Berufserfahrung nicht vorausgesetzt
Region
Deutschland (Hessen)
Arbeitsort
60438 Frankfurt am Main
Fachgebiet
Biologie & Life Sciences, Pharma
JETZT BEWERBEN